Wednesday, December 27, 2023

Hey Everyone!

I've basically let this page go fallow, as I was encountering various issues that I just didn't have time to address. Apologies for that.

I may take another swing at this in 2024 to see if I can make this site more usable. What is more likely, though, is that I will migrate to Substack. Much of what I do there will be like what I do here - links to articles published on other sites - but I think I may start putting some original content there (and that will probably be behind a paywall).

If anybody is still reading here and has thoughts about this, feel free to share.

I wish everyone a very happy, healthy, and prosperous New Year!

Wednesday, January 25, 2023

Synovus Delivering On Growth And Leverage

 There have long been vocal doubters on Synovus (NYSE:SNV), and the company’s share price performance over the last couple of years has lagged its peer group, but with above-average fourth quarter results and guidance for

 Read the full article here: 

Synovus Delivering On Growth And Leverage

Friday, January 20, 2023

Consistency Carrying Commerce Bancshares

I believe that at least part of the reason that investors are willing to bid up Commerce Bancshares (NASDAQ:CBSH) to above-average multiples is that this bank is built to weather the ups and

 

Click the link to continue to the full article: 

Consistency Carrying Commerce Bancshares

Truist Looks Better Placed Than Many Banks For Better Growth In 2023

Banking is all about leverage, and Truist (NYSE:TFC) looks to be better-placed than most peer banks to drive rate and operating leverage in 2023, setting the bank up for relatively better operating performance. In the context of what I think

 

Click here to continue: 

Truist Looks Better Placed Than Many Banks For Better Growth In 2023

UnitedHealth Seems Curiously Undervalued Given Multiple Growth Drivers

In a business where scale is king UnitedHealth (NYSE:UNH) has all the scale that an investor could ask for and more. What’s more, the company has actively built and pursued attractive growth opportunities outside of

 

Click here to continue: 

UnitedHealth Seems Curiously Undervalued Given Multiple Growth Drivers

Fulton Financial Could Use More Core Growth Leverage

It’s still early in the fourth quarter reporting cycle, but so far the bank sector is not having the easiest time. The main drivers aren’t all that surprising to me – I’ve been writing about the threats presented by rising deposit betas, weaker operating leverage, and


Read the full article here: 

Fulton Financial Could Use More Core Growth Leverage

First Republic Planting The Seeds For A Later Harvest

It may be an exaggeration to say that 2023 is a lost year for First Republic (NYSE:FRC), particularly in mid January, but I don’t think it’s an exaggeration to say that the results this bank will post this year

Follow this link for the full article: 

First Republic Planting The Seeds For A Later Harvest

JPMorgan Executing Well In Challenging Times And Still Undervalued

This year is likely to be one where management and business quality, as well as past strategic decisions, really show up in the results of bank companies. Most banks will likely see net interest margins peak between Q4’22 and Q2’23, operating leverage will be

The full article can be found here: 

JPMorgan Executing Well In Challenging Times And Still Undervalued

Keysight Technologies Offers Enough Quality Growth To Support A Robust Valuation

There are plenty of sayings (and cliches) regarding valuation and quality in the investment world, but it is nevertheless true that quality, value, and price are all distinct characteristics. I mention this because I think it’s an important backdrop for looking at Keysight Technologies (

 

Read more here: 

Keysight Technologies Offers Enough Quality Growth To Support A Robust Valuation

Cirrus Logic's Current Valuation Seems Less Than Completely Logical

A carefully cultivated skepticism can be an investor’s best friend, and when a stock looks too cheap, it’s absolutely a good idea to wonder why. In the case of Cirrus Logic (NASDAQ:CRUS), I understand concerns about

To continue reading, follow this link: 

Cirrus Logic's Current Valuation Seems Less Than Completely Logical

Penumbra Riding Higher On Upcoming Launches And Rerating

When I last wrote about Penumbra (NYSE:PEN) in August of 2022 I was bullish on the company based on the prospects for meaningful upcoming product launches and a material rerating for the shares. This has largely panned out

 

Follow this link to the full article: 

Penumbra Riding Higher On Upcoming Launches And Rerating

Power Integrations Seeing A Temporary Brownout

Even differentiated growth stories are often bounded by the performance of the underlying markets they serve, and so it seems with Power Integrations (NASDAQ:POWI). After a soft third quarter that saw 13% sequential revenue contraction, management guided to even weaker

 

Read more here: 

Power Integrations Seeing A Temporary Brownout

Cosan: Volatility In SEE Markets Only Adds To The Complexity

Brazilian conglomerate Cosan (NYSE:CSAN) is a complicated story in the best of times, as this company pursues a holding company structure to invest in a wide range of businesses, including its Raizen joint venture with Shell (

 

Click the link for the full article: 

Cosan: Volatility In SEE Markets Only Adds To The Complexity

S&W Seed: Trying To Thread The Needle With A Refreshed Product Lineup And Growth Strategy

It's been a while since I've written about S&W Seed Company (NASDAQ:SANW) and the intervening period has not been particularly kind to this small ag-tech company. The company has continued to struggle to get

 

Read the full article here: 

S&W Seed: Trying To Thread The Needle With A Refreshed Product Lineup And Growth Strategy

SKF's Rally Into 2023 Seems Overdone

Industrials have certainly recovered of late. With investors feeling more confident that the impending downturn will be mild and that rate hikes are close to an end, the industrials have climbed about 20% over the last three months, and Sweden’s

Read more here: 

SKF's Rally Into 2023 Seems Overdone

EnPro Becoming A Slimmer, More Profitable, And Less Cyclical Multi-Industrial

EnPro (NYSE:NPO) management has been transparent about its intentions to continue to remake the company into a more niche-oriented multi-industrial focused on less-cyclical, faster-growing markets, and with a product portfolio more skewed to high barriers to

 

The full article is available here: 

EnPro Becoming A Slimmer, More Profitable, And Less Cyclical Multi-Industrial

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Teleflex (NYSE:TFX) goes into 2023 needing to prove that the company can get the business growing back to a level more in line with investor expectations, and that includes the key UroLift product. The company

 

Read the full article here: 

Teleflex Already Getting A Pretty Good Benefit Of The Doubt

Adecoagro Hit Hard By A Weakening Outlook For Ethanol And Sugar Production

Brazil’s Adecoagro (NYSE:AGRO) is a good case-in-point that a commodity company can do everything right (or at least do many things right) and still see larger commodity and economic trends, and investor worries about those trends, undo that hard work. Adecoagro, for its

 

Continue reading here: 

Adecoagro Hit Hard By A Weakening Outlook For Ethanol And Sugar Production

Housing Turbulence Could Open A Window Of Opportunity With Rayonier

While it’s true that timberlands can be a good investment category over time (if bought and managed properly), it doesn’t automatically follow that timber REITs are a can’t-miss investment opportunity, as the market has frequently assigned robust multiples to these businesses. In

 

Click here to continue: 

Housing Turbulence Could Open A Window Of Opportunity With Rayonier

Acuity Continues To Execute, But Weaker Non-Resi Trends Seem To Be Weighing On Shares

One of the more frustrating investment situations to be in is to see a company executing a little better than expected, but see the shares drift lower anyway. Such is the case with Acuity Brands

 

Read the full article here: 

Acuity Continues To Execute, But Weaker Non-Resi Trends Seem To Be Weighing On Shares

Alnylam Pharmaceuticals Starts 2023 With In-Line Revenue And A Full Slate Of Clinical Read-Outs

This will be another busy year for Alnylam Pharmaceuticals (NASDAQ:ALNY), as this leading RNAi biotech expects to release clinical updates on five different clinical programs, in addition to anticipated updates from partnered programs and multiple potential IND filings. Though the

Follow this link to the full article: 

 Alnylam Pharmaceuticals Starts 2023 With In-Line Revenue And A Full Slate Of Clinical Read-Outs

Cycle Worries Weighing On Renesas Electronics And Creating A Bargain Valuation

Semiconductor stocks are off their lows, but I certainly wouldn’t say that sentiment is particularly healthy – lead-times have started to shrink and companies have started openly acknowledging customers inquiring about pushouts (if not outright cancelations). With declining ASPs likely to push total industry revenue

 

The full article can be found here: 

Cycle Worries Weighing On Renesas Electronics And Creating A Bargain Valuation

A Turn In Short-Cycle Industrial Demand Only Adds To IPG Photonics' Challenges

IPG Photonics (NASDAQ:IPGP) has continued to have a difficult time of it. Russia’s invasion of Ukraine, and the sanctions that followed, were always going to make 2022 more challenging for the company, but IPG Photonics has also had to deal with interruptions

 

Read the full article at Seeking Alpha: 

A Turn In Short-Cycle Industrial Demand Only Adds To IPG Photonics' Challenges

Beaten-Down MaxLinear Starting To Look More Interesting

The last year has been a rough one for MaxLinear (NASDAQ:MXL), with the shares down about 46% (underperforming the broader semiconductor market by almost 20%) despite strong growth in the company’s WiFi connectivity business. Not only have investors become more cautious

 

Click the link to continue: 

Beaten-Down MaxLinear Starting To Look More Interesting

Cycle Worries Have Opened A Window Of Opportunity At Shin-Etsu Chemical

Even the best companies aren’t immune to macro challenges, and that’s certainly the case these days at Shin-Etsu Chemical (OTCPK:SHECY) (4063.T) (“Shin-Etsu”). One of the best-run companies I know in the broader chemical space (and perhaps

 

Read the full article here: 

Cycle Worries Have Opened A Window Of Opportunity At Shin-Etsu Chemical

Saturday, January 7, 2023

A Mostly Clean Quarter Drives A Better Valuation For AngioDynamics

At least some of the sharp decline in AngioDynamics (NASDAQ:ANGO) after its disappointing fiscal first quarter report in October of 2022 could be tied to fears that there was another shoe to drop, and likewise, the


Click the link for more: 

A Mostly Clean Quarter Drives A Better Valuation For AngioDynamics

Hurco Closes The Fiscal Year Strong, But Not Quite In The Clear Yet

The industrial sector has been a more interesting place of late. While there are still troubling signs for 2023, including higher rates, contracting manufacturing PMI, and weakening business confidence, the market has been more willing to look for "buy the dip" opportunities and the sector has

 

Click the link to continue: 

Hurco Closes The Fiscal Year Strong, But Not Quite In The Clear Yet

MSC Industrial Lagging Despite On-Target Performance

Industrial stocks have held up rather well over the last three months, with investors apparently more confident that the risks to 2023 are priced in now and that the Fed’s efforts to stomp out inflation won’t lead to significant demand destruction. Despite

 

Read the full article here: 

MSC Industrial Lagging Despite On-Target Performance

Constellation Brands: Demand And Margin Concerns Drive A Selloff

There has long been above-average volatility at Constellation Brands (NYSE:STZ) around quarterly earnings reports, and going into this fiscal third quarter report there were some elevated concerns about slowing volume growth. With weaker-than-expected depletions and worse

 

Read more here: 

Constellation Brands: Demand And Margin Concerns Drive A Selloff

Texas Instruments Well Placed For The Long Haul, But Not Especially Cheap Today

Texas Instruments’ (NASDAQ:TXN) (“TI”) track records of exceptional margins and market share are no accident, and management has not been afraid to break from the pack to chart its own course (including decisions to build inventory when others cut production, using price

 

Follow the link for the full article: 

Texas Instruments Well Placed For The Long Haul, But Not Especially Cheap Today

Performance Food Group Has Ample Scale, But Margins Need To Get Better

Distribution is a tough business, but one that rewards scale and particularly scale combined with efficiency. This is something that giant food distributor Sysco (SYY) understands well, but that other rivals like Performance Food Group (

 

Read the full article here: 

Performance Food Group Has Ample Scale, But Margins Need To Get Better

FB Financial: It's Going To Get Worse Before It Gets Better

With the Fed hiking interest rates another 50bp as of this writing and signaling a willingness to go even further, it's going to be even harder to be in the banking business over the next several

 

Continue here: 

FB Financial: It's Going To Get Worse Before It Gets Better

The Rebound At Terex Should Have Legs

While the 2023 outlook for many industries is getting more frightful, the recent trading in Terex (NYSE:TEX) and other heavy machinery names has been pretty delightful, with Terex up more than 65% from its summer lows

 

To read the full article, follow this link: 

The Rebound At Terex Should Have Legs

Smith & Nephew: Potential Only Has Value If You Can Execute

Long a laggard in the ortho space, I was more bullish on Smith & Nephew (NYSE:SNN) last September on what I thought were cogent plans from a relatively new management to address and reverse this long-term pattern

 

Follow the link to the full article: 

Smith & Nephew: Potential Only Has Value If You Can Execute

Cadence Bank: Better Growth And Betas, But It Will Get Harder From Here

The early returns from the merger that created the new Cadence Bank (NYSE:CADE) have been mixed - while the bank is performing well operationally, the stock has been lagging the regional banking group and has

 

Click here to continue: 

Cadence Bank: Better Growth And Betas, But It Will Get Harder From Here

Atlas Copco: Still Excellent, Still Expensive, And Maybe A Bit Vulnerable

There may be better industrial companies out there than Atlas Copco (OTCPK:ATLKY), but the number of entries above them on that list is going to be relatively few. Few companies have matched Atlas when it comes to a margin-rich, asset-light

 

Read the full article here: 

Atlas Copco: Still Excellent, Still Expensive, And Maybe A Bit Vulnerable

Tuesday, December 13, 2022

Constellation Brands: Executing Well And Gaining Share, With More To Come

My positive thesis on Constellation Brands (NYSE:STZ) back in August of 2021 was predicated on meaningful volume share growth potential for the company’s Modelo and Corona brands, as well as further improvement potential in the wine business, and this has played out well over the last 16 months, with Constellation continuing to gain share in the U.S. market, while the shares have outperformed (up almost 11%) other beer rivals like Molson Coors (TAP) (by 300bp), ABI (BUD) (by about 1,100bp), Heineken (OTCQX:HEINY) (by over 2,300bp), and Carlsberg (OTCPK:CABGY) (by about 2,700bp), as well as the broader consumer staples space.

Constellation is still under-leveraged on national distribution and under-leveraged to on-premises, but management continues to work at both, with evident progress over the last year (and beyond). While trade-down and tougher comps are an emerging risk, and I do see some margin vulnerability in the short term, Constellation still looks undervalued to me and worth a closer look.

 

Click the link for the full article: 

Constellation Brands: Executing Well And Gaining Share, With More To Come

Sensata Technologies Beaten And Battered By Macro And Margins, But Still Leveraged To Electrification

This has been another tough year for companies leveraged to the passenger vehicle market. The year started off with projections of mid-to-high single-digit unit growth in vehicles for the U.S. market, but semiconductor and component shortages have decimated that forecast, with actual year-to-date sales trending down about 9% (this is production-driven, as inventories are still thin). At the same time, electronic component shortages and other inflationary drivers have made life difficult on the margin side for many companies.

Sensata Technologies (NYSE:ST) has seen its share price fall a little more than 20% since my last update. While I suppose that’s not terrible next to other broadly comparable suppliers to the auto and commercial vehicle markets, including Aptiv (APTV), Dana (DAN), and TE Connectivity (TEL), it’s not the year I expected for this sensing and controls company, and 2023 isn’t offering much in the way of macro certainty.

I do think that Sensata looks undervalued, but I also thought that in the high-$50’s. Now Sensata is looking at a potentially softer auto demand environment, as well as weaker trends for highway/off-road business and industrial markets. Provided that mid-single-digit growth is still viable, which I believe it is given the company’s higher EV content and its growth opportunities elsewhere in electrification, these shares offer a worthwhile return at today’s price.

 

Read more here: 

Sensata Technologies Beaten And Battered By Macro And Margins, But Still Leveraged To Electrification

Hammered By Input And Launch Costs, Nidec Is Worth Another Look

The last year and a half has been a brutal one for Nidec (OTCPK:NJDCY) (6594.T), with the local shares down more than a third and the ADRs down closer to 50% since my last update. Nidec has been hit hard not only by a downturn in high-margin spindle motors for hard disk drives (or HDDs), but also much higher input costs and launch costs for its emerging EV auto business (e-axles). If that wasn’t bad enough, a weaker outlook for motors used in appliances and HVAC systems is also weighing on sentiment.

The investment case for Nidec used to be more of a battle about the right multiple to pay, as Nidec shares historically traded at rich multiples. While the sharp pullback has helped the longer-term valuation argument, the shares still remain pricey on more conventional short-term multiples-based approaches. While I do like Nidec’s leverage to vehicle electrification, a weaker market for consumer electronics could persist and Nidec has significant sentiment headwinds to overcome.

 

Follow this link for the full article: 

Hammered By Input And Launch Costs, Nidec Is Worth Another Look

Cognex Languishing Through A Painful Reset Of A Major Growth Market

It would have been difficult to be more wrong about Cognex (NASDAQ:CGNX) than my call back in April that, despite challenges in the logistics market (warehouse automation), this machine vision company would still manage double-digit growth in 2022. In fact, Cognex is likely looking at not only a revenue decline in 2022, but quite possibly a decline in 2023 as well given weaker macro trends. With weaker end-market demand (and a fire at a manufacturing partner), Cognex is on pace for far less in terms of profitability and cash flow than I’d expected, and it may not be “business as usual” until 2024/2025.

Down about a third since my last ill-fated update, Cognex has been a notable laggard in an otherwise flattish market for other automation names like Datalogic (OTC:DLGCF), Fanuc (OTCPK:FANUY), Keyence (OTCPK:KYCCF), Rockwell (ROK), and Yaskawa (OTCPK:YASKY), though KION (OTCPK:KIGRY), another logistics-driven name, has been even weaker. While I do see long-term value in the name here, it’ll be difficult for sentiment to turn with logistics revenue likely down 20%-plus again in 2023, particularly if other end-markets weaken more than seems to be baked into sell-side expectations.

 

Continue here: 

Cognex Languishing Through A Painful Reset Of A Major Growth Market

High Costs And Macro Worries Drag Cemex Down

My bullish call on Cemex (NYSE:CX) in February was predicated on strong volumes and pricing in the U.S. driving better profits and cash flow, with a healthy outlook for increasing infrastructure spending supporting the longer-term view. While U.S. demand and pricing have both been healthy, the market has become considerably more nervous about 2023 and Cemex has fallen short on profitability, leading to a 20% drop in the stock price and underperformance in an admittedly lackluster cement sector (though Eagle (EXP), GCC, and Martin Marietta (MLM) have held up better).

I’m increasingly concerned about what look like structural cost issues at Cemex that seem likely to lead to longer-term underperformance in profitability. That said, I do think infrastructure demand is likely to remain quite supportive and today’s price seems to reflect an overly bearish outlook for the company. Management has most definitely not earned the benefit of the doubt here, but if the company can manage something on the order of 4% long-term EBITDA growth, I do think there is some value here.

 

Read the full article here: 

High Costs And Macro Worries Drag Cemex Down